Medical Care
Global Stem Cell Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 11, 25
- ID: 304213
- Pages: 130
- Figures: 120
- Views: 4
In 2024, the global market size of Stem Cell Therapy was estimated to be worth US$ 685 million and is forecast to reach approximately US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
North America is the largest Stem Cell Therapy market with about 65% market share. Europe is follower, accounting for about 16% market share.
The key players are Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell, Medi-post, Anterogen, Molmed, Takeda (TiGenix) etc. Top 3 companies occupied about 38% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Therapy.
The Stem Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Stem Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Stem Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Osiris Therapeutics
NuVasive
Chiesi Pharmaceuticals
JCR Pharmaceutical
Pharmicell
Medi-post
Anterogen
Molmed
Takeda (TiGenix)
Segment by Type
Autologous
Allogeneic
Segment by Application
Musculoskeletal Disorder
Wounds & Injuries
Cornea
Cardiovascular Diseases
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Stem Cell Therapy in global and regional level.
Chapter 3: Detailed analysis of Stem Cell Therapy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Stem Cell Therapy revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
North America is the largest Stem Cell Therapy market with about 65% market share. Europe is follower, accounting for about 16% market share.
The key players are Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell, Medi-post, Anterogen, Molmed, Takeda (TiGenix) etc. Top 3 companies occupied about 38% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Therapy.
The Stem Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Stem Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Stem Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Osiris Therapeutics
NuVasive
Chiesi Pharmaceuticals
JCR Pharmaceutical
Pharmicell
Medi-post
Anterogen
Molmed
Takeda (TiGenix)
Segment by Type
Autologous
Allogeneic
Segment by Application
Musculoskeletal Disorder
Wounds & Injuries
Cornea
Cardiovascular Diseases
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Stem Cell Therapy in global and regional level.
Chapter 3: Detailed analysis of Stem Cell Therapy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Stem Cell Therapy revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Stem Cell Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Stem Cell Therapy Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Autologous
1.2.3 Allogeneic
1.3 Market by Application
1.3.1 Global Stem Cell Therapy Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Musculoskeletal Disorder
1.3.3 Wounds & Injuries
1.3.4 Cornea
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Stem Cell Therapy Market Size Estimates and Forecasts
2.2 Stem Cell Therapy Market Size by Region: 2024 Versus 2031
2.2.1 Global Stem Cell Therapy Revenue by Region: 2020-2025
2.2.2 Global Stem Cell Therapy Revenue Forecast by Region (2026-2031)
2.2.3 Global Stem Cell Therapy Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Stem Cell Therapy Revenue by Type (2020-2031)
3.1.2 Global Stem Cell Therapy Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Stem Cell Therapy Revenue by Application (2020-2031)
3.2.2 Global Stem Cell Therapy Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Autologous of Stem Cell Therapy Revenue Market Share by Application
3.3.2 Allogeneic of Stem Cell Therapy Revenue Market Share by Application
4 Global Stem Cell Therapy by Company
4.1 Global Stem Cell Therapy Revenue by Company (2020-2025)
4.2 Global Stem Cell Therapy Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Stem Cell Therapy Companies around the World: Ranking by Revenue
4.3.2 Global Stem Cell Therapy Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Stem Cell Therapy Companies Headquarters & Product Type
4.4.1 Global Stem Cell Therapy Companies Headquarters
4.4.2 Date of International Companies Enter into Stem Cell Therapy Market
4.4.3 Global Stem Cell Therapy Companies Product & Service
4.4.4 Autologous Revenue Market Share of Stem Cell Therapy by Company
4.4.5 Allogeneic Revenue Market Share of Stem Cell Therapy by Company
4.5 Global Stem Cell Therapy Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Osiris Therapeutics
5.1.1 Osiris Therapeutics Corporation Information
5.1.2 Osiris Therapeutics Description, Business Overview
5.1.3 Osiris Therapeutics Stem Cell Therapy Products Offered
5.1.4 Osiris Therapeutics Stem Cell Therapy Revenue and Gross Margin (2020-2025)
5.1.5 Osiris Therapeutics Stem Cell Therapy Revenue by Product in 2024
5.1.6 Osiris Therapeutics Stem Cell Therapy Revenue by Application in 2024
5.1.7 Osiris Therapeutics Stem Cell Therapy Revenue by Geographic Area in 2024
5.1.8 Osiris Therapeutics Recent Developments
5.2 NuVasive
5.2.1 NuVasive Corporation Information
5.2.2 NuVasive Description, Business Overview
5.2.3 NuVasive Stem Cell Therapy Products Offered
5.2.4 NuVasive Stem Cell Therapy Revenue and Gross Margin (2020-2025)
5.2.5 NuVasive Stem Cell Therapy Revenue by Product in 2024
5.2.6 NuVasive Stem Cell Therapy Revenue by Application in 2024
5.2.7 NuVasive Stem Cell Therapy Revenue by Geographic Area in 2024
5.2.8 NuVasive Recent Developments
5.3 Chiesi Pharmaceuticals
5.3.1 Chiesi Pharmaceuticals Corporation Information
5.3.2 Chiesi Pharmaceuticals Description, Business Overview
5.3.3 Chiesi Pharmaceuticals Stem Cell Therapy Products Offered
5.3.4 Chiesi Pharmaceuticals Stem Cell Therapy Revenue and Gross Margin (2020-2025)
5.3.5 Chiesi Pharmaceuticals Stem Cell Therapy Revenue by Product in 2024
5.3.6 Chiesi Pharmaceuticals Stem Cell Therapy Revenue by Application in 2024
5.3.7 Chiesi Pharmaceuticals Stem Cell Therapy Revenue by Geographic Area in 2024
5.3.8 Chiesi Pharmaceuticals Recent Developments
5.4 JCR Pharmaceutical
5.4.1 JCR Pharmaceutical Corporation Information
5.4.2 JCR Pharmaceutical Description, Business Overview
5.4.3 JCR Pharmaceutical Stem Cell Therapy Products Offered
5.4.4 JCR Pharmaceutical Stem Cell Therapy Revenue and Gross Margin (2020-2025)
5.4.5 JCR Pharmaceutical Stem Cell Therapy Revenue by Product in 2024
5.4.6 JCR Pharmaceutical Stem Cell Therapy Revenue by Application in 2024
5.4.7 JCR Pharmaceutical Stem Cell Therapy Revenue by Geographic Area in 2024
5.4.8 JCR Pharmaceutical Recent Developments
5.5 Pharmicell
5.5.1 Pharmicell Corporation Information
5.5.2 Pharmicell Description, Business Overview
5.5.3 Pharmicell Stem Cell Therapy Products Offered
5.5.4 Pharmicell Stem Cell Therapy Revenue and Gross Margin (2020-2025)
5.5.5 Pharmicell Stem Cell Therapy Revenue by Product in 2024
5.5.6 Pharmicell Stem Cell Therapy Revenue by Application in 2024
5.5.7 Pharmicell Stem Cell Therapy Revenue by Geographic Area in 2024
5.5.8 Pharmicell Recent Developments
5.6 Medi-post
5.6.1 Medi-post Corporation Information
5.6.2 Medi-post Description, Business Overview
5.6.3 Medi-post Stem Cell Therapy Products Offered
5.6.4 Medi-post Stem Cell Therapy Revenue and Gross Margin (2020-2025)
5.6.5 Medi-post Stem Cell Therapy Revenue by Product in 2024
5.6.6 Medi-post Stem Cell Therapy Revenue by Application in 2024
5.6.7 Medi-post Stem Cell Therapy Revenue by Geographic Area in 2024
5.6.8 Medi-post Recent Developments
5.7 Anterogen
5.7.1 Anterogen Corporation Information
5.7.2 Anterogen Description, Business Overview
5.7.3 Anterogen Stem Cell Therapy Products Offered
5.7.4 Anterogen Stem Cell Therapy Revenue and Gross Margin (2020-2025)
5.7.5 Anterogen Stem Cell Therapy Revenue by Product in 2024
5.7.6 Anterogen Stem Cell Therapy Revenue by Application in 2024
5.7.7 Anterogen Stem Cell Therapy Revenue by Geographic Area in 2024
5.7.8 Anterogen Recent Developments
5.8 Molmed
5.8.1 Molmed Corporation Information
5.8.2 Molmed Description, Business Overview
5.8.3 Molmed Stem Cell Therapy Products Offered
5.8.4 Molmed Stem Cell Therapy Revenue and Gross Margin (2020-2025)
5.8.5 Molmed Stem Cell Therapy Revenue by Product in 2024
5.8.6 Molmed Stem Cell Therapy Revenue by Application in 2024
5.8.7 Molmed Stem Cell Therapy Revenue by Geographic Area in 2024
5.8.8 Molmed Recent Developments
5.9 Takeda (TiGenix)
5.9.1 Takeda (TiGenix) Corporation Information
5.9.2 Takeda (TiGenix) Description, Business Overview
5.9.3 Takeda (TiGenix) Stem Cell Therapy Products Offered
5.9.4 Takeda (TiGenix) Stem Cell Therapy Revenue and Gross Margin (2020-2025)
5.9.5 Takeda (TiGenix) Stem Cell Therapy Revenue by Product in 2024
5.9.6 Takeda (TiGenix) Stem Cell Therapy Revenue by Application in 2024
5.9.7 Takeda (TiGenix) Stem Cell Therapy Revenue by Geographic Area in 2024
5.9.8 Takeda (TiGenix) Recent Developments
6 North America
6.1 North America Stem Cell Therapy Market Size YoY Growth 2020-2031
6.2 North America Stem Cell Therapy Market Facts & Figures by Country (2020-2031)
6.3 North America Stem Cell Therapy Revenue by Type (2020-2025)
6.4 North America Stem Cell Therapy Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Stem Cell Therapy Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Stem Cell Therapy Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Stem Cell Therapy Revenue by Type (2020-2025)
7.4 Asia-Pacific Stem Cell Therapy Revenue by Application (2020-2025)
8 Europe
8.1 Europe Stem Cell Therapy Market Size YoY Growth 2020-2031
8.2 Europe Stem Cell Therapy Market Facts & Figures by Country (2020-2031)
8.3 Europe Stem Cell Therapy Revenue by Type (2020-2025)
8.4 Europe Stem Cell Therapy Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Stem Cell Therapy Market Size YoY Growth 2020-2031
9.2 Latin America Stem Cell Therapy Market Facts & Figures by Country (2020-2031)
9.3 Latin America Stem Cell Therapy Revenue by Type (2020-2025)
9.4 Latin America Stem Cell Therapy Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Stem Cell Therapy Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Stem Cell Therapy Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Stem Cell Therapy Revenue by Type (2020-2025)
10.4 Middle East and Africa Stem Cell Therapy Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Stem Cell Therapy Supply Chain Analysis
11.2 Stem Cell Therapy Key Raw Materials and Upstream Suppliers
11.3 Stem Cell Therapy Clients Analysis
11.4 Stem Cell Therapy Sales Channel and Sales Model Analysis
11.4.1 Stem Cell Therapy Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Stem Cell Therapy Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Stem Cell Therapy Distributors
12 Stem Cell Therapy Market Dynamics
12.1 Stem Cell Therapy Industry Trends
12.2 Stem Cell Therapy Market Drivers
12.3 Stem Cell Therapy Market Challenges
12.4 Stem Cell Therapy Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Stem Cell Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Stem Cell Therapy Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Autologous
1.2.3 Allogeneic
1.3 Market by Application
1.3.1 Global Stem Cell Therapy Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Musculoskeletal Disorder
1.3.3 Wounds & Injuries
1.3.4 Cornea
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Stem Cell Therapy Market Size Estimates and Forecasts
2.2 Stem Cell Therapy Market Size by Region: 2024 Versus 2031
2.2.1 Global Stem Cell Therapy Revenue by Region: 2020-2025
2.2.2 Global Stem Cell Therapy Revenue Forecast by Region (2026-2031)
2.2.3 Global Stem Cell Therapy Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Stem Cell Therapy Revenue by Type (2020-2031)
3.1.2 Global Stem Cell Therapy Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Stem Cell Therapy Revenue by Application (2020-2031)
3.2.2 Global Stem Cell Therapy Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Autologous of Stem Cell Therapy Revenue Market Share by Application
3.3.2 Allogeneic of Stem Cell Therapy Revenue Market Share by Application
4 Global Stem Cell Therapy by Company
4.1 Global Stem Cell Therapy Revenue by Company (2020-2025)
4.2 Global Stem Cell Therapy Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Stem Cell Therapy Companies around the World: Ranking by Revenue
4.3.2 Global Stem Cell Therapy Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Stem Cell Therapy Companies Headquarters & Product Type
4.4.1 Global Stem Cell Therapy Companies Headquarters
4.4.2 Date of International Companies Enter into Stem Cell Therapy Market
4.4.3 Global Stem Cell Therapy Companies Product & Service
4.4.4 Autologous Revenue Market Share of Stem Cell Therapy by Company
4.4.5 Allogeneic Revenue Market Share of Stem Cell Therapy by Company
4.5 Global Stem Cell Therapy Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Osiris Therapeutics
5.1.1 Osiris Therapeutics Corporation Information
5.1.2 Osiris Therapeutics Description, Business Overview
5.1.3 Osiris Therapeutics Stem Cell Therapy Products Offered
5.1.4 Osiris Therapeutics Stem Cell Therapy Revenue and Gross Margin (2020-2025)
5.1.5 Osiris Therapeutics Stem Cell Therapy Revenue by Product in 2024
5.1.6 Osiris Therapeutics Stem Cell Therapy Revenue by Application in 2024
5.1.7 Osiris Therapeutics Stem Cell Therapy Revenue by Geographic Area in 2024
5.1.8 Osiris Therapeutics Recent Developments
5.2 NuVasive
5.2.1 NuVasive Corporation Information
5.2.2 NuVasive Description, Business Overview
5.2.3 NuVasive Stem Cell Therapy Products Offered
5.2.4 NuVasive Stem Cell Therapy Revenue and Gross Margin (2020-2025)
5.2.5 NuVasive Stem Cell Therapy Revenue by Product in 2024
5.2.6 NuVasive Stem Cell Therapy Revenue by Application in 2024
5.2.7 NuVasive Stem Cell Therapy Revenue by Geographic Area in 2024
5.2.8 NuVasive Recent Developments
5.3 Chiesi Pharmaceuticals
5.3.1 Chiesi Pharmaceuticals Corporation Information
5.3.2 Chiesi Pharmaceuticals Description, Business Overview
5.3.3 Chiesi Pharmaceuticals Stem Cell Therapy Products Offered
5.3.4 Chiesi Pharmaceuticals Stem Cell Therapy Revenue and Gross Margin (2020-2025)
5.3.5 Chiesi Pharmaceuticals Stem Cell Therapy Revenue by Product in 2024
5.3.6 Chiesi Pharmaceuticals Stem Cell Therapy Revenue by Application in 2024
5.3.7 Chiesi Pharmaceuticals Stem Cell Therapy Revenue by Geographic Area in 2024
5.3.8 Chiesi Pharmaceuticals Recent Developments
5.4 JCR Pharmaceutical
5.4.1 JCR Pharmaceutical Corporation Information
5.4.2 JCR Pharmaceutical Description, Business Overview
5.4.3 JCR Pharmaceutical Stem Cell Therapy Products Offered
5.4.4 JCR Pharmaceutical Stem Cell Therapy Revenue and Gross Margin (2020-2025)
5.4.5 JCR Pharmaceutical Stem Cell Therapy Revenue by Product in 2024
5.4.6 JCR Pharmaceutical Stem Cell Therapy Revenue by Application in 2024
5.4.7 JCR Pharmaceutical Stem Cell Therapy Revenue by Geographic Area in 2024
5.4.8 JCR Pharmaceutical Recent Developments
5.5 Pharmicell
5.5.1 Pharmicell Corporation Information
5.5.2 Pharmicell Description, Business Overview
5.5.3 Pharmicell Stem Cell Therapy Products Offered
5.5.4 Pharmicell Stem Cell Therapy Revenue and Gross Margin (2020-2025)
5.5.5 Pharmicell Stem Cell Therapy Revenue by Product in 2024
5.5.6 Pharmicell Stem Cell Therapy Revenue by Application in 2024
5.5.7 Pharmicell Stem Cell Therapy Revenue by Geographic Area in 2024
5.5.8 Pharmicell Recent Developments
5.6 Medi-post
5.6.1 Medi-post Corporation Information
5.6.2 Medi-post Description, Business Overview
5.6.3 Medi-post Stem Cell Therapy Products Offered
5.6.4 Medi-post Stem Cell Therapy Revenue and Gross Margin (2020-2025)
5.6.5 Medi-post Stem Cell Therapy Revenue by Product in 2024
5.6.6 Medi-post Stem Cell Therapy Revenue by Application in 2024
5.6.7 Medi-post Stem Cell Therapy Revenue by Geographic Area in 2024
5.6.8 Medi-post Recent Developments
5.7 Anterogen
5.7.1 Anterogen Corporation Information
5.7.2 Anterogen Description, Business Overview
5.7.3 Anterogen Stem Cell Therapy Products Offered
5.7.4 Anterogen Stem Cell Therapy Revenue and Gross Margin (2020-2025)
5.7.5 Anterogen Stem Cell Therapy Revenue by Product in 2024
5.7.6 Anterogen Stem Cell Therapy Revenue by Application in 2024
5.7.7 Anterogen Stem Cell Therapy Revenue by Geographic Area in 2024
5.7.8 Anterogen Recent Developments
5.8 Molmed
5.8.1 Molmed Corporation Information
5.8.2 Molmed Description, Business Overview
5.8.3 Molmed Stem Cell Therapy Products Offered
5.8.4 Molmed Stem Cell Therapy Revenue and Gross Margin (2020-2025)
5.8.5 Molmed Stem Cell Therapy Revenue by Product in 2024
5.8.6 Molmed Stem Cell Therapy Revenue by Application in 2024
5.8.7 Molmed Stem Cell Therapy Revenue by Geographic Area in 2024
5.8.8 Molmed Recent Developments
5.9 Takeda (TiGenix)
5.9.1 Takeda (TiGenix) Corporation Information
5.9.2 Takeda (TiGenix) Description, Business Overview
5.9.3 Takeda (TiGenix) Stem Cell Therapy Products Offered
5.9.4 Takeda (TiGenix) Stem Cell Therapy Revenue and Gross Margin (2020-2025)
5.9.5 Takeda (TiGenix) Stem Cell Therapy Revenue by Product in 2024
5.9.6 Takeda (TiGenix) Stem Cell Therapy Revenue by Application in 2024
5.9.7 Takeda (TiGenix) Stem Cell Therapy Revenue by Geographic Area in 2024
5.9.8 Takeda (TiGenix) Recent Developments
6 North America
6.1 North America Stem Cell Therapy Market Size YoY Growth 2020-2031
6.2 North America Stem Cell Therapy Market Facts & Figures by Country (2020-2031)
6.3 North America Stem Cell Therapy Revenue by Type (2020-2025)
6.4 North America Stem Cell Therapy Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Stem Cell Therapy Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Stem Cell Therapy Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Stem Cell Therapy Revenue by Type (2020-2025)
7.4 Asia-Pacific Stem Cell Therapy Revenue by Application (2020-2025)
8 Europe
8.1 Europe Stem Cell Therapy Market Size YoY Growth 2020-2031
8.2 Europe Stem Cell Therapy Market Facts & Figures by Country (2020-2031)
8.3 Europe Stem Cell Therapy Revenue by Type (2020-2025)
8.4 Europe Stem Cell Therapy Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Stem Cell Therapy Market Size YoY Growth 2020-2031
9.2 Latin America Stem Cell Therapy Market Facts & Figures by Country (2020-2031)
9.3 Latin America Stem Cell Therapy Revenue by Type (2020-2025)
9.4 Latin America Stem Cell Therapy Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Stem Cell Therapy Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Stem Cell Therapy Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Stem Cell Therapy Revenue by Type (2020-2025)
10.4 Middle East and Africa Stem Cell Therapy Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Stem Cell Therapy Supply Chain Analysis
11.2 Stem Cell Therapy Key Raw Materials and Upstream Suppliers
11.3 Stem Cell Therapy Clients Analysis
11.4 Stem Cell Therapy Sales Channel and Sales Model Analysis
11.4.1 Stem Cell Therapy Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Stem Cell Therapy Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Stem Cell Therapy Distributors
12 Stem Cell Therapy Market Dynamics
12.1 Stem Cell Therapy Industry Trends
12.2 Stem Cell Therapy Market Drivers
12.3 Stem Cell Therapy Market Challenges
12.4 Stem Cell Therapy Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Stem Cell Therapy Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Stem Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Stem Cell Therapy Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Stem Cell Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Stem Cell Therapy Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Stem Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Stem Cell Therapy Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Stem Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Stem Cell Therapy Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Stem Cell Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 11. Stem Cell Therapy Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Stem Cell Therapy Players by Revenue (US$ Million) in 2024
Table 13. Global Stem Cell Therapy Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Stem Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy as of 2024)
Table 15. Global Stem Cell Therapy Companies Headquarters
Table 16. Date of International Companies Enter into Stem Cell Therapy Market
Table 17. Global Stem Cell Therapy Companies Product & Service
Table 18. Global Stem Cell Therapy Mergers & Acquisitions, Expansion Plans
Table 19. Osiris Therapeutics Corporation Information
Table 20. Osiris Therapeutics Description and Business Overview
Table 21. Osiris Therapeutics Stem Cell Therapy Product
Table 22. Osiris Therapeutics Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Osiris Therapeutics Revenue Proportion of Stem Cell Therapy by Product in 2024
Table 24. Osiris Therapeutics Revenue Proportion of Stem Cell Therapy by Application in 2024
Table 25. Osiris Therapeutics Revenue Proportion of Stem Cell Therapy by Geographic Area in 2024
Table 26. Osiris Therapeutics Recent Developments
Table 27. NuVasive Corporation Information
Table 28. NuVasive Description and Business Overview
Table 29. NuVasive Stem Cell Therapy Product
Table 30. NuVasive Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. NuVasive Revenue Proportion of Stem Cell Therapy by Product in 2024
Table 32. NuVasive Revenue Proportion of Stem Cell Therapy by Application in 2024
Table 33. NuVasive Revenue Proportion of Stem Cell Therapy by Geographic Area in 2024
Table 34. NuVasive Recent Developments
Table 35. Chiesi Pharmaceuticals Corporation Information
Table 36. Chiesi Pharmaceuticals Description and Business Overview
Table 37. Chiesi Pharmaceuticals Stem Cell Therapy Product
Table 38. Chiesi Pharmaceuticals Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Chiesi Pharmaceuticals Revenue Proportion of Stem Cell Therapy by Product in 2024
Table 40. Chiesi Pharmaceuticals Revenue Proportion of Stem Cell Therapy by Application in 2024
Table 41. Chiesi Pharmaceuticals Revenue Proportion of Stem Cell Therapy by Geographic Area in 2024
Table 42. Chiesi Pharmaceuticals Recent Developments
Table 43. JCR Pharmaceutical Corporation Information
Table 44. JCR Pharmaceutical Description and Business Overview
Table 45. JCR Pharmaceutical Stem Cell Therapy Product
Table 46. JCR Pharmaceutical Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. JCR Pharmaceutical Revenue Proportion of Stem Cell Therapy by Product in 2024
Table 48. JCR Pharmaceutical Revenue Proportion of Stem Cell Therapy by Application in 2024
Table 49. JCR Pharmaceutical Revenue Proportion of Stem Cell Therapy by Geographic Area in 2024
Table 50. JCR Pharmaceutical Recent Developments
Table 51. Pharmicell Corporation Information
Table 52. Pharmicell Description and Business Overview
Table 53. Pharmicell Stem Cell Therapy Product
Table 54. Pharmicell Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Pharmicell Revenue Proportion of Stem Cell Therapy by Product in 2024
Table 56. Pharmicell Revenue Proportion of Stem Cell Therapy by Application in 2024
Table 57. Pharmicell Revenue Proportion of Stem Cell Therapy by Geographic Area in 2024
Table 58. Pharmicell Recent Developments
Table 59. Medi-post Corporation Information
Table 60. Medi-post Description and Business Overview
Table 61. Medi-post Stem Cell Therapy Product
Table 62. Medi-post Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Medi-post Revenue Proportion of Stem Cell Therapy by Product in 2024
Table 64. Medi-post Revenue Proportion of Stem Cell Therapy by Application in 2024
Table 65. Medi-post Revenue Proportion of Stem Cell Therapy by Geographic Area in 2024
Table 66. Medi-post Recent Developments
Table 67. Anterogen Corporation Information
Table 68. Anterogen Description and Business Overview
Table 69. Anterogen Stem Cell Therapy Product
Table 70. Anterogen Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Anterogen Revenue Proportion of Stem Cell Therapy by Product in 2024
Table 72. Anterogen Revenue Proportion of Stem Cell Therapy by Application in 2024
Table 73. Anterogen Revenue Proportion of Stem Cell Therapy by Geographic Area in 2024
Table 74. Anterogen Recent Developments
Table 75. Molmed Corporation Information
Table 76. Molmed Description and Business Overview
Table 77. Molmed Stem Cell Therapy Product
Table 78. Molmed Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Molmed Revenue Proportion of Stem Cell Therapy by Product in 2024
Table 80. Molmed Revenue Proportion of Stem Cell Therapy by Application in 2024
Table 81. Molmed Revenue Proportion of Stem Cell Therapy by Geographic Area in 2024
Table 82. Molmed Recent Developments
Table 83. Takeda (TiGenix) Corporation Information
Table 84. Takeda (TiGenix) Description and Business Overview
Table 85. Takeda (TiGenix) Stem Cell Therapy Product
Table 86. Takeda (TiGenix) Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Takeda (TiGenix) Revenue Proportion of Stem Cell Therapy by Product in 2024
Table 88. Takeda (TiGenix) Revenue Proportion of Stem Cell Therapy by Application in 2024
Table 89. Takeda (TiGenix) Revenue Proportion of Stem Cell Therapy by Geographic Area in 2024
Table 90. Takeda (TiGenix) Recent Developments
Table 91. North America Stem Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 92. North America Stem Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 93. North America Stem Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 94. North America Stem Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 95. Asia-Pacific Stem Cell Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 96. Asia-Pacific Stem Cell Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 97. Asia-Pacific Stem Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 98. Asia-Pacific Stem Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 99. Europe Stem Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 100. Europe Stem Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 101. Europe Stem Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 102. Europe Stem Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 103. Latin America Stem Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 104. Latin America Stem Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 105. Latin America Stem Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 106. Latin America Stem Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 107. Middle East and Africa Stem Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 108. Middle East and Africa Stem Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 109. Middle East and Africa Stem Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 110. Middle East and Africa Stem Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 111. Stem Cell Therapy Key Raw Materials, Industry Status and Trend
Table 112. Stem Cell Therapy Key Raw Materials and Upstream Suppliers
Table 113. Stem Cell Therapy Clients Status and Trend
Table 114. Stem Cell Therapy Typical Clients
Table 115. Stem Cell Therapy Distributors
Table 116. Stem Cell Therapy Market Trends
Table 117. Stem Cell Therapy Market Drivers
Table 118. Stem Cell Therapy Market Challenges
Table 119. Stem Cell Therapy Market Restraints
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Stem Cell Therapy Product Picture
Figure 2. Global Stem Cell Therapy Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Stem Cell Therapy Revenue Market Share by Type in 2024 & 2031
Figure 4. Autologous Product Picture
Figure 5. Allogeneic Product Picture
Figure 6. Global Stem Cell Therapy Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Stem Cell Therapy Revenue Market Share by Application in 2024 & 2031
Figure 8. Musculoskeletal Disorder
Figure 9. Wounds & Injuries
Figure 10. Cornea
Figure 11. Cardiovascular Diseases
Figure 12. Others
Figure 13. Stem Cell Therapy Report Years Considered
Figure 14. Global Stem Cell Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Stem Cell Therapy Market Size (2020-2031) & (US$ Million)
Figure 16. Global Stem Cell Therapy Market Size Market Share by Region: 2024 Versus 2031
Figure 17. Global Stem Cell Therapy Revenue Market Share by Region (2020-2031)
Figure 18. Global Stem Cell Therapy Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Global Stem Cell Therapy Revenue Market Share Forecast by Application (2020-2031)
Figure 20. Autologous of Stem Cell Therapy Revenue Market Share by Application, 2024 VS 2031
Figure 21. Allogeneic of Stem Cell Therapy Revenue Market Share by Application, 2024 VS 2031
Figure 22. Stem Cell Therapy Revenue Share by Company (2024)
Figure 23. Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Autologous Revenue Proportion by Company in 2024
Figure 25. Allogeneic Revenue Proportion by Company in 2024
Figure 26. North America Stem Cell Therapy Revenue 2020-2031 (US$ Million)
Figure 27. North America Stem Cell Therapy Revenue Market Share by Type (2020-2025)
Figure 28. North America Stem Cell Therapy Revenue Market Share by Application (2020-2025)
Figure 29. Asia-Pacific Stem Cell Therapy Revenue 2020-2031 (US$ Million)
Figure 30. Asia-Pacific Stem Cell Therapy Revenue Market Share by Region (2020-2031)
Figure 31. Asia-Pacific Stem Cell Therapy Revenue Market Share by Type (2020-2025)
Figure 32. Asia-Pacific Stem Cell Therapy Revenue Market Share by Application (2020-2025)
Figure 33. Europe Stem Cell Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 34. Europe Stem Cell Therapy Revenue Market Share by Country (2020-2031)
Figure 35. Europe Stem Cell Therapy Revenue Market Share by Type (2020-2025)
Figure 36. Europe Stem Cell Therapy Revenue Market Share by Application (2020-2025)
Figure 37. Latin America Stem Cell Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Latin America Stem Cell Therapy Revenue Market Share by Country (2020-2031)
Figure 39. Latin America Stem Cell Therapy Revenue Market Share by Type (2020-2025)
Figure 40. Latin America Stem Cell Therapy Revenue Market Share by Application (2020-2025)
Figure 41. Middle East and Africa Stem Cell Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Middle East and Africa Stem Cell Therapy Revenue Market Share by Country (2020-2031)
Figure 43. Middle East and Africa Stem Cell Therapy Revenue Market Share by Type (2020-2025)
Figure 44. Middle East and Africa Stem Cell Therapy Revenue Market Share by Application (2020-2025)
Figure 45. Stem Cell Therapy Supply Chain (Upstream and Downstream Market)
Figure 46. Global Production Market Share of Stem Cell Therapy Raw Materials by Region in 2024
Figure 47. Stem Cell Therapy Distribution Channels
Figure 48. Global Stem Cell Therapy Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 49. Global Stem Cell Therapy Percentage 2020-2031: Online Sales VS Offline Sales
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Table 1. Global Stem Cell Therapy Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Stem Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Stem Cell Therapy Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Stem Cell Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Stem Cell Therapy Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Stem Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Stem Cell Therapy Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Stem Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Stem Cell Therapy Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Stem Cell Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 11. Stem Cell Therapy Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Stem Cell Therapy Players by Revenue (US$ Million) in 2024
Table 13. Global Stem Cell Therapy Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Stem Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy as of 2024)
Table 15. Global Stem Cell Therapy Companies Headquarters
Table 16. Date of International Companies Enter into Stem Cell Therapy Market
Table 17. Global Stem Cell Therapy Companies Product & Service
Table 18. Global Stem Cell Therapy Mergers & Acquisitions, Expansion Plans
Table 19. Osiris Therapeutics Corporation Information
Table 20. Osiris Therapeutics Description and Business Overview
Table 21. Osiris Therapeutics Stem Cell Therapy Product
Table 22. Osiris Therapeutics Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Osiris Therapeutics Revenue Proportion of Stem Cell Therapy by Product in 2024
Table 24. Osiris Therapeutics Revenue Proportion of Stem Cell Therapy by Application in 2024
Table 25. Osiris Therapeutics Revenue Proportion of Stem Cell Therapy by Geographic Area in 2024
Table 26. Osiris Therapeutics Recent Developments
Table 27. NuVasive Corporation Information
Table 28. NuVasive Description and Business Overview
Table 29. NuVasive Stem Cell Therapy Product
Table 30. NuVasive Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. NuVasive Revenue Proportion of Stem Cell Therapy by Product in 2024
Table 32. NuVasive Revenue Proportion of Stem Cell Therapy by Application in 2024
Table 33. NuVasive Revenue Proportion of Stem Cell Therapy by Geographic Area in 2024
Table 34. NuVasive Recent Developments
Table 35. Chiesi Pharmaceuticals Corporation Information
Table 36. Chiesi Pharmaceuticals Description and Business Overview
Table 37. Chiesi Pharmaceuticals Stem Cell Therapy Product
Table 38. Chiesi Pharmaceuticals Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Chiesi Pharmaceuticals Revenue Proportion of Stem Cell Therapy by Product in 2024
Table 40. Chiesi Pharmaceuticals Revenue Proportion of Stem Cell Therapy by Application in 2024
Table 41. Chiesi Pharmaceuticals Revenue Proportion of Stem Cell Therapy by Geographic Area in 2024
Table 42. Chiesi Pharmaceuticals Recent Developments
Table 43. JCR Pharmaceutical Corporation Information
Table 44. JCR Pharmaceutical Description and Business Overview
Table 45. JCR Pharmaceutical Stem Cell Therapy Product
Table 46. JCR Pharmaceutical Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. JCR Pharmaceutical Revenue Proportion of Stem Cell Therapy by Product in 2024
Table 48. JCR Pharmaceutical Revenue Proportion of Stem Cell Therapy by Application in 2024
Table 49. JCR Pharmaceutical Revenue Proportion of Stem Cell Therapy by Geographic Area in 2024
Table 50. JCR Pharmaceutical Recent Developments
Table 51. Pharmicell Corporation Information
Table 52. Pharmicell Description and Business Overview
Table 53. Pharmicell Stem Cell Therapy Product
Table 54. Pharmicell Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Pharmicell Revenue Proportion of Stem Cell Therapy by Product in 2024
Table 56. Pharmicell Revenue Proportion of Stem Cell Therapy by Application in 2024
Table 57. Pharmicell Revenue Proportion of Stem Cell Therapy by Geographic Area in 2024
Table 58. Pharmicell Recent Developments
Table 59. Medi-post Corporation Information
Table 60. Medi-post Description and Business Overview
Table 61. Medi-post Stem Cell Therapy Product
Table 62. Medi-post Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Medi-post Revenue Proportion of Stem Cell Therapy by Product in 2024
Table 64. Medi-post Revenue Proportion of Stem Cell Therapy by Application in 2024
Table 65. Medi-post Revenue Proportion of Stem Cell Therapy by Geographic Area in 2024
Table 66. Medi-post Recent Developments
Table 67. Anterogen Corporation Information
Table 68. Anterogen Description and Business Overview
Table 69. Anterogen Stem Cell Therapy Product
Table 70. Anterogen Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Anterogen Revenue Proportion of Stem Cell Therapy by Product in 2024
Table 72. Anterogen Revenue Proportion of Stem Cell Therapy by Application in 2024
Table 73. Anterogen Revenue Proportion of Stem Cell Therapy by Geographic Area in 2024
Table 74. Anterogen Recent Developments
Table 75. Molmed Corporation Information
Table 76. Molmed Description and Business Overview
Table 77. Molmed Stem Cell Therapy Product
Table 78. Molmed Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Molmed Revenue Proportion of Stem Cell Therapy by Product in 2024
Table 80. Molmed Revenue Proportion of Stem Cell Therapy by Application in 2024
Table 81. Molmed Revenue Proportion of Stem Cell Therapy by Geographic Area in 2024
Table 82. Molmed Recent Developments
Table 83. Takeda (TiGenix) Corporation Information
Table 84. Takeda (TiGenix) Description and Business Overview
Table 85. Takeda (TiGenix) Stem Cell Therapy Product
Table 86. Takeda (TiGenix) Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Takeda (TiGenix) Revenue Proportion of Stem Cell Therapy by Product in 2024
Table 88. Takeda (TiGenix) Revenue Proportion of Stem Cell Therapy by Application in 2024
Table 89. Takeda (TiGenix) Revenue Proportion of Stem Cell Therapy by Geographic Area in 2024
Table 90. Takeda (TiGenix) Recent Developments
Table 91. North America Stem Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 92. North America Stem Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 93. North America Stem Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 94. North America Stem Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 95. Asia-Pacific Stem Cell Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 96. Asia-Pacific Stem Cell Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 97. Asia-Pacific Stem Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 98. Asia-Pacific Stem Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 99. Europe Stem Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 100. Europe Stem Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 101. Europe Stem Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 102. Europe Stem Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 103. Latin America Stem Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 104. Latin America Stem Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 105. Latin America Stem Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 106. Latin America Stem Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 107. Middle East and Africa Stem Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 108. Middle East and Africa Stem Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 109. Middle East and Africa Stem Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 110. Middle East and Africa Stem Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 111. Stem Cell Therapy Key Raw Materials, Industry Status and Trend
Table 112. Stem Cell Therapy Key Raw Materials and Upstream Suppliers
Table 113. Stem Cell Therapy Clients Status and Trend
Table 114. Stem Cell Therapy Typical Clients
Table 115. Stem Cell Therapy Distributors
Table 116. Stem Cell Therapy Market Trends
Table 117. Stem Cell Therapy Market Drivers
Table 118. Stem Cell Therapy Market Challenges
Table 119. Stem Cell Therapy Market Restraints
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Stem Cell Therapy Product Picture
Figure 2. Global Stem Cell Therapy Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Stem Cell Therapy Revenue Market Share by Type in 2024 & 2031
Figure 4. Autologous Product Picture
Figure 5. Allogeneic Product Picture
Figure 6. Global Stem Cell Therapy Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Stem Cell Therapy Revenue Market Share by Application in 2024 & 2031
Figure 8. Musculoskeletal Disorder
Figure 9. Wounds & Injuries
Figure 10. Cornea
Figure 11. Cardiovascular Diseases
Figure 12. Others
Figure 13. Stem Cell Therapy Report Years Considered
Figure 14. Global Stem Cell Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Stem Cell Therapy Market Size (2020-2031) & (US$ Million)
Figure 16. Global Stem Cell Therapy Market Size Market Share by Region: 2024 Versus 2031
Figure 17. Global Stem Cell Therapy Revenue Market Share by Region (2020-2031)
Figure 18. Global Stem Cell Therapy Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Global Stem Cell Therapy Revenue Market Share Forecast by Application (2020-2031)
Figure 20. Autologous of Stem Cell Therapy Revenue Market Share by Application, 2024 VS 2031
Figure 21. Allogeneic of Stem Cell Therapy Revenue Market Share by Application, 2024 VS 2031
Figure 22. Stem Cell Therapy Revenue Share by Company (2024)
Figure 23. Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Autologous Revenue Proportion by Company in 2024
Figure 25. Allogeneic Revenue Proportion by Company in 2024
Figure 26. North America Stem Cell Therapy Revenue 2020-2031 (US$ Million)
Figure 27. North America Stem Cell Therapy Revenue Market Share by Type (2020-2025)
Figure 28. North America Stem Cell Therapy Revenue Market Share by Application (2020-2025)
Figure 29. Asia-Pacific Stem Cell Therapy Revenue 2020-2031 (US$ Million)
Figure 30. Asia-Pacific Stem Cell Therapy Revenue Market Share by Region (2020-2031)
Figure 31. Asia-Pacific Stem Cell Therapy Revenue Market Share by Type (2020-2025)
Figure 32. Asia-Pacific Stem Cell Therapy Revenue Market Share by Application (2020-2025)
Figure 33. Europe Stem Cell Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 34. Europe Stem Cell Therapy Revenue Market Share by Country (2020-2031)
Figure 35. Europe Stem Cell Therapy Revenue Market Share by Type (2020-2025)
Figure 36. Europe Stem Cell Therapy Revenue Market Share by Application (2020-2025)
Figure 37. Latin America Stem Cell Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Latin America Stem Cell Therapy Revenue Market Share by Country (2020-2031)
Figure 39. Latin America Stem Cell Therapy Revenue Market Share by Type (2020-2025)
Figure 40. Latin America Stem Cell Therapy Revenue Market Share by Application (2020-2025)
Figure 41. Middle East and Africa Stem Cell Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Middle East and Africa Stem Cell Therapy Revenue Market Share by Country (2020-2031)
Figure 43. Middle East and Africa Stem Cell Therapy Revenue Market Share by Type (2020-2025)
Figure 44. Middle East and Africa Stem Cell Therapy Revenue Market Share by Application (2020-2025)
Figure 45. Stem Cell Therapy Supply Chain (Upstream and Downstream Market)
Figure 46. Global Production Market Share of Stem Cell Therapy Raw Materials by Region in 2024
Figure 47. Stem Cell Therapy Distribution Channels
Figure 48. Global Stem Cell Therapy Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 49. Global Stem Cell Therapy Percentage 2020-2031: Online Sales VS Offline Sales
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232